Literature DB >> 15808639

Factors predicting duration of delayed graft function in non-heart-beating donor kidney transplantation.

J Asher1, C Wilson, M Gok, S Balupuri, A A Bhatti, N Soomro, D Rix, B Jaques, D Manas, B Shenton, D Talbot.   

Abstract

Non-heart-beating donors (NHBDs) are an important potential source of donor organs, but kidneys from such donors are prone to delayed graft function (DGF) and primary nonfunction, which are multifactorial in origin but believed to be mainly due to warm ischemic injury. This retrospective study examined a series of 88 transplants from Maastricht category II and III NHBDs to examine the role of factors to predict the duration of DGF. The main factors affecting duration of DGF were total warm ischemic time, cold ischemic time, product of perfusate GST concentration and donor age, quality of postoperative graft perfusion, incidence of acute rejection, recipient cardiovascular risk score, maximum pressure on machine perfusion, and weight gain during machine perfusion. Primary nonfunction was not accurately predicted from these factors for kidneys that had passed the viability assessment.

Entities:  

Mesh:

Year:  2005        PMID: 15808639     DOI: 10.1016/j.transproceed.2004.11.036

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Anti-donor MHC Class II Alloantibody Induces Glomerular Injury in Mouse Renal Allografts Subjected to Prolonged Cold Ischemia.

Authors:  Victoria Gorbacheva; Ran Fan; Ashley Beavers; Robert L Fairchild; William M Baldwin; Anna Valujskikh
Journal:  J Am Soc Nephrol       Date:  2019-10-09       Impact factor: 10.121

2.  Extracorporeal support: improves donor renal graft function after cardiac death.

Authors:  A Rojas-Pena; J L Reoma; E Krause; E L Boothman; N P Padiyar; K E Cook; R H Bartlett; J D Punch
Journal:  Am J Transplant       Date:  2010-06       Impact factor: 8.086

3.  A Prospective Randomised Paired Trial of Sirolimus versus Tacrolimus as Primary Immunosuppression following Non-Heart Beating Donor Kidney Transplantation.

Authors:  John Asher; Nikhil Vasdev; Hugh Wyrley-Birch; Colin Wilson; Naeem Soomro; David Rix; Bryon Jaques; Derek Manas; Nicholas Torpey; David Talbot
Journal:  Curr Urol       Date:  2014-08-20

Review 4.  Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: a systematic review.

Authors:  Ronik S Bhangoo; Isaac E Hall; Peter P Reese; Chirag R Parikh
Journal:  Nephrol Dial Transplant       Date:  2012-04-11       Impact factor: 5.992

5.  Prediction of delayed graft function after renal transplantation.

Authors:  Claudio Jeldres; Héloïse Cardinal; Alain Duclos; Shahrokh F Shariat; Nazareno Suardi; Umberto Capitanio; Marie-Josèe Hébert; Pierre I Karakiewicz
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

6.  Analysis of machine perfusion benefits in kidney grafts: a preclinical study.

Authors:  Nader Vaziri; Raphaël Thuillier; Frederic D Favreau; Michel Eugene; Serge Milin; Nicolas P Chatauret; Thierry Hauet; Benoit Barrou
Journal:  J Transl Med       Date:  2011-01-25       Impact factor: 5.531

7.  Vectisol Formulation Enhances Solubility of Resveratrol and Brings Its Benefits to Kidney Transplantation in a Preclinical Porcine Model.

Authors:  David Soussi; Jérôme Danion; Edouard Baulier; Frédéric Favreau; Ysé Sauvageon; Valentin Bossard; Xavier Matillon; Frédéric Turpin; El Mustapha Belgsir; Raphaël Thuillier; Thierry Hauet
Journal:  Int J Mol Sci       Date:  2019-05-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.